Deep Brain Stimulation shows promise for patients with Alzheimer's

Aug 04, 2010

In a world first, Dr. Andres M. Lozano and his team at Toronto Western Hospital has shown using Deep Brain Stimulation (DBS) on patients with early signs of Alzheimer's disease is safe and may help improve memory.

The phase one safety trial of six Ontario patients took place from 2005 to 2008. All patients left hospital within 2 to 3 days of surgery, and continue to participate in regular follow-up cognitive assessments.

Throughout these assessments, Dr. Lozano says half the patients continue to perform better than predicted - that is - their has improved, or deteriorated less than expected.

"While the study was not looking for efficacy, the results suggest that of the six patients, three may have done better than if the was allowed to run its course," commented Lozano. "We showed that not only is this a safe procedure, but that the evidence is there to warrant a bigger trial. Any amount of time that extends quality of life and quality years to someone with Alzheimer's may be a benefit."

Dr. Lozano first discovered the potential for DBS to treat Alzheimer's disease while treating a patient for using DBS back in 2003. While signaling areas of the brain, Dr. Lozano and his team triggered memories in the patient. In follow-up testing the patient's improved and Dr. Lozano set in motion the first ever DBS trial of patients with early signs of Alzheimer's disease.

"We've demonstrated this is safe, and that the evidence warrants more study. We're now planning a phase two, multi-centred trial - we're just waiting on the funding," says Dr. Lozano.

Explore further: Statin use during hospitalization for hemorrhagic stroke associated with improved survival

More information: Results of Dr. Lozano's trial are published in today's issue of Annals of Neurology.

Provided by University Health Network

4 /5 (2 votes)

Related Stories

Deep brain stimulation may improve memory

Jan 30, 2008

Deep brain stimulation (DBS) surgery, which is used to treat Parkinson’s disease and other movement disorders, is now being studied for its potential to treat a variety of conditions. For example, DBS of the hypothalamus ...

Researchers find new Alzheimer's disease treatment promising

Jul 12, 2009

Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The ...

MRI shows brain atrophy pattern that predicts Alzheimer's

Feb 10, 2009

Using special MRI methods, researchers have identified a pattern of regional brain atrophy in patients with mild cognitive impairment (MCI) that indicates a greater likelihood of progression to Alzheimer's disease. The findings ...

Drug shows promise for Huntington's disease

Feb 08, 2010

An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition. That is the conclusion of a study published today in the Archives of ...

Recommended for you

User comments : 0